Separately, NICE has recommended pembrolizumab as a possible treatment for adults with melanoma that can’t be completely removed by surgery or has spread to other parts of the body, and has been treated with ipilimumab (melanoma that is BRAF V600 mutation-positive must also have had treatment with vemurafenib, dabrafenib, or trametinib).